Hepmarin

Medicarb AB

This company develops biocompatible surface coating technologies and heparin-based wound healing agents for medical device manufacturers and healthcare providers.

HemostOD

The company develops stem cell-derived platelets for transfusion and targeted drug delivery, serving healthcare providers and pharmaceutical partners treating blood disorders or trauma.

Vestland Pharma AS

This company develops a natural treatment using oceanic compounds to remove salmon lice for the aquaculture industry.

Aplagon

This company develops heparin proteoglycan mimetics to treat thrombo-inflammatory diseases in patients with cardiovascular conditions such as chronic limb-threatening ischaemia.

ExCulture

This company develops animal-free heparin alternatives using mixed-culture fermentation for the cosmetics, medical technology and pharmaceutical industries.

Haermonics

This company develops automated pericardial flushing systems to prevent blood clots and drainage complications for patients recovering from open-heart surgery.

Omeza

This company develops marine-derived wound care products using fish peptides for healthcare providers treating patients with chronic or hard-to-heal skin ulcers.

VarmX

This biotech company develops recombinant blood clotting factors to treat patients with severe bleeding or requiring urgent surgery while taking oral anticoagulants.